It does look bad, but it is interesting that both the chairman and another director bought reasonable amounts of shares in the last couple of weeks.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025